One Drop today announced positive results from a trial of its digital health platform for people with type 2 diabetes.
Employees using the One Drop digital diabetes management platform experienced significant productivity and functioning gains and were less likely to experience presenteeism at follow-up compared to control groups.
One Drop’s platform uses AI to provide direct support through eight-hour glucose forecasts with better than 90% accuracy and immediate insights delivered to users. The company said this feature simplifies healthy decision-making by connecting everyday behaviors with outcomes and offering ongoing guidance to complement the support members receive from healthcare providers.
The One Drop platform combines connected medical devices, an AI-powered mobile app (iOS and Android, available in 11 languages), and one-on-one coaching with certified diabetes care and education specialists to enable people with chronic conditions to manage their health.
Results from New York-based One Drop’s randomized controlled trial were published in the Journal of Occupational Environmental Medicine, according to a news release.
The study demonstrated that One Drop is an “economical solution yielding substantial benefits for adults with type 2 diabetes,” the company said. Employees aged 50 and older using One Drop saved 8% of their time at work and 17% of on-the-job productivity, equating to $422 and $12,733 in average worker savings per year, respectively.
One Drop said the latest clinical trial results suggest that the platform may enable better day-to-day functioning for people managing their diabetes. The company cited possible reasons for this, including the reduction of treatment-related burnout, removal of health-related stress or distractions, and increased concentration and energy.
“A healthy and productive workforce is critical for economic success and population health. Leaders who recognize this vital connection are investing in technology, like One Drop, that helps people function better day-to-day at work—where the average employee spends a third of their life,” said Jeff Dachis, CEO and founder of One Drop. “When combined with established clinical, psychological, and behavioral outcomes, productivity gains paint a complete picture of how our predictive health platform positively impacts all aspects of someone’s life—at home, at work, and beyond.”
The company said it is also developing a minimally invasive health sensor with continuous glucose monitoring (CGM) capabilities to offer greater flexibility and insights for people with diabetes. Should it garner regulatory approval, One Drop said it will integrate the proprietary sensor with its existing digital offering to augment outcomes and cost savings for those with diabetes and other chronic conditions.